What it is
U.S. federal and most state laws require or recommend erythromycin 0.5% ophthalmic ointment for every newborn within the first hour or so after birth, regardless of the birth parent's STI screening results. Its main target is Neisseria gonorrhoeae. It does not reliably treat chlamydial conjunctivitis (which usually appears later and is treated with oral antibiotics if it develops).
Evidence review links
Each link opens the full review on the publisher's site in a new tab.
Possible benefits
- Prevents gonococcal eye infection, a leading historical cause of newborn blindness[US Preventive Services Task Force↗][American Academy of Pediatrics↗]
- Simple, one-time application, low cost[American Academy of Pediatrics↗]
Possible risks
- Blurs the baby's vision briefly, which can interfere with the first hour of eye contact and bonding — timing can often be delayed 1 hour[American Academy of Pediatrics↗]
- Mild eye irritation; very rare allergic reaction[American Academy of Pediatrics↗]
- Doesn't cover chlamydia — parents should still watch for eye discharge in the first weeks[American Academy of Pediatrics↗]
Alternatives
- Delay application by up to an hour to protect the first breastfeed and eye contact[American Academy of Pediatrics↗]
- Declining where legally allowed — reasonable to discuss if the birth parent has recent negative gonorrhea screening and low risk, but state laws vary[US Preventive Services Task Force↗]
Current evidence
USPSTF gives ocular prophylaxis a Grade A recommendation. AAP endorses erythromycin as the standard agent. Silver nitrate and povidone-iodine are alternatives used in other countries.
Where the evidence is clear · where people may choose differently
For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.
Educational only. Your care team can help you weigh what applies to your specific situation.
Related evidence topics
- Vitamin K at BirthNewborns are born low in vitamin K, which the blood needs to clot. A single injection at birth virtually eliminates a rare but devastating bleeding disorder called VKDB (vitamin K deficiency bleeding).
- Skin-to-Skin After BirthPlacing the naked baby directly on the parent's bare chest at birth (and beyond) — a small change with meaningful benefits for feeding, temperature, and bonding.
- Hepatitis B Vaccine at BirthThe first of a 3-dose Hep B vaccine series, given within 24 hours of birth. It's a cornerstone of preventing chronic Hep B infection, which can silently cause liver disease decades later.
Questions to ask your care team
- ?Can we delay the ointment for the first hour of skin-to-skin?
- ?Is it required by law in this state, or can we decline?
- ?What signs of eye infection should we watch for in the first weeks?
Universal questions (works for any decision)
A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.
- ?Why are you recommending this now — is it urgent, routine, or optional?
- ?What happens if we wait an hour (or longer) before deciding?
- ?What signs would tell us this is working — or that we need to change course?
- ?What are the alternatives, including doing nothing?
- ?What would you recommend if this were your family?
- ?What would change your recommendation?
Sources & provenance
Tap a source to open the original guideline or review in a new tab.
- USPSTF: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum — US Preventive Services Task Force
- Red Book: Prevention of Neonatal Ophthalmia — American Academy of Pediatrics
Plain-language paraphrase. Re-verify before publish.
Last reviewed: 2026-07-03
Further reading — canonical references
Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.
Tier 1 · Clinical guidelines
Tier 2 · Systematic reviews
Tier 3 · Childbirth-specific
Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.
Version history — v1.0.0
v1.0.0 · 2026-07-03 · LlaMamma editors
Initial erythromycin eye ointment topic.
New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.
